Charles Explorer logo
🇬🇧

Cardiac resynchronization therapy implantation following transcatheter aortic valve implantation

Publication at First Faculty of Medicine, Third Faculty of Medicine |
2011

Abstract

The conduction defects in patients following transcatheter aortic valve implantation (TAVI) are common and difficult to predict. Whether a pacemaker (and which type) should be implanted in this particular group of patients remains a question.

We report on the case of a TAVI patient initially implanted with a DDD pacemaker, who substantially profited from a later upgrade to a cardiac resynchronization therapy.